Showing results (211-220 of 327) with videos related to

Sort By:
Pageof 33
The Journal of Allergy and Clinical Immunology|February 20, 2021
Benralizumab for adolescent patients with severe, eosinophilic asthma: Safety and efficacy after 3 years of treatmentWilliam W Busse, Eugene R Bleecker, J Mark FitzGerald, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|October 28, 2008
An evaluation of patients' willingness to trade symptom-free days for asthma-related treatment risks: a discrete choice experimentHelen M McTaggart-Cowan, Peilin Shi, J Mark Fitzgerald, et al.
Canadian Respiratory Journal|December 18, 2003
Adjustable maintenance dosing with budesonide/formoterol reduces asthma exacerbations compared with traditional fixed dosing: a five-month multicentre Canadian studyJ Mark FitzGerald, Malcolm R Sears, Louis-Philippe Boulet, et al.
Patient Education and Counseling|February 24, 2020
Asthma and COPD patients' perceived link between health literacy core domains and self-management of their conditionIraj Poureslami, Jessica Shum, Roger Goldstein, et al.
The New England Journal of Medicine|May 17, 2018
Inhaled Combined Budesonide-Formoterol as Needed in Mild AsthmaPaul M O'Byrne, J Mark FitzGerald, Eric D Bateman, et al.
Pharmacogenomics|September 19, 2009
Genetic variations of NAT2 and CYP2E1 and isoniazid hepatotoxicity in a diverse populationSo Yamada, Mila Tang, Kathryn Richardson, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|November 13, 2017
Efficacy and safety of benralizumab in Japanese patients with severe, uncontrolled eosinophilic asthmaKen Ohta, Mitsuru Adachi, Yuji Tohda, et al.
Pageof 33